Skip to main content
. 2021 Aug 10;4(8):e2119118. doi: 10.1001/jamanetworkopen.2021.19118

Table 3. Estimated Relative Risk of Pertussis Comparing Children Who Were Undervaccinated or Vaccinated With Delay With Those Who Received Age-Appropriate and Timely DTaP Vaccine Using Log-Binomial Models.

Model Cohort Cohort size Start follow-up time, mo End follow-up time, mo PT at risk in exposed, mo PT at risk in unexposed, mo Cases exposeda Cases unexposedb aRR (95% CI)c
Primary series
Undervaccinated with or without delay vs age-appropriate and timely vaccination Children ≥7 mo 298 166 7 19 949 469.4 2 671 653 54 31 4.8 (3.1-7.6)
Delayed vs timely doses among those with age-appropriate vaccination Children ≥7 mo who received ≥3 doses 257 913 7 19 492 272.2 2 671 653 5 31 0.8 (0.3-2.2)
First booster
Undervaccinated with or without delay vs age-appropriate and timely vaccination Children ≥19 mo 258 675 19 60 2 598 849 5 360 429 99 59 3.2 (2.3-4.5)
Delayed vs timely doses among those with age-appropriate vaccination Children ≥19 mo who received ≥4 doses 221 928 19 60 1 732 007 5 360 429 17 59 0.8 (0.5-1.4)
Second booster
Undervaccinated with or without delay vs age-appropriate and timely vaccination Children ≥60 mo 134 950 60 Age censored /end of study 1 327 522 2 664 899 38 17 4.6 (2.6-8.2)
Delayed vs timely doses among age-appropriately vaccinated Children ≥60 mo or older who received ≥5 doses 111 387 60 Age censored/end of study 580 387.7 2 664 899 5 17 1.3 (0.5-3.6)
Series initiation
Undervaccinated with or without delay dose 1 vs age-appropriate and timely vaccination for primary series Children ≥3 mo 301 494 3 12 579 975.3 3 006 319 38 54 3.5 (2.3-5.5)
Delayed vs timely dose 1 among age-appropriately vaccinated for primary series Children ≥3 mo who received 3 doses by 7 mo of age 295 325 3 12 64 926.5 2 555 811 0 41 NA
3p vs 2p + 1 scheduled Children ≥3 mo 301 494 3 24 4 870 512 307 677.8 1 60 3.9 (0.5-28.8)

Abbreviations: aRR, adjusted relative risk; DTaP, diphtheria-tetanus–acellular pertussis; PT, person-time.

a

Exposed group: undervaccination with or without vaccination delay for models assessing effect of undervaccination on pertussis risk and vaccination delay for models assessing effect of vaccination delay only on pertussis risk.

b

Unexposed group: age-appropriate and timely vaccination with DTaP vaccine.

c

Adjusted relative risk are risk ratios adjusted for age and Neighborhood Socioeconomic Status score.

d

The term “3p” indicates accelerated 3-dose DTaP primary series to be administered at ages 2, 4, and 6 months; “2p + 1” indicates long 3-dose DTaP primary series to be administered at ages 2, 4, and 11/12 months; 2p + 1 is the exposed group.